1. Home
  2. BV vs CAPR Comparison

BV vs CAPR Comparison

Compare BV & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BrightView Holdings Inc.

BV

BrightView Holdings Inc.

HOLD

Current Price

$14.06

Market Cap

1.4B

ML Signal

HOLD

Logo Capricor Therapeutics Inc.

CAPR

Capricor Therapeutics Inc.

HOLD

Current Price

$19.70

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BV
CAPR
Founded
1939
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2018
2011

Fundamental Metrics

Financial Performance
Metric
BV
CAPR
Price
$14.06
$19.70
Analyst Decision
Hold
Strong Buy
Analyst Count
5
8
Target Price
$14.50
$44.63
AVG Volume (30 Days)
973.3K
1.8M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.61
N/A
Revenue Next Year
$1.90
$3.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.06
$4.30
52 Week High
$16.46
$40.37

Technical Indicators

Market Signals
Indicator
BV
CAPR
Relative Strength Index (RSI) 54.09 32.70
Support Level $12.52 $5.25
Resistance Level $14.88 $30.39
Average True Range (ATR) 0.37 1.30
MACD -0.09 0.01
Stochastic Oscillator 34.07 25.71

Price Performance

Historical Comparison
BV
CAPR

About BV BrightView Holdings Inc.

BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Share on Social Networks: